DRUG | SUPPLIED | DOSE | COMMENTS |
---|---|---|---|
MOMETASONE (Paeds) (Elocom, Nasonex) Mechanism of action: Corticosteroid Ref: 44, 415, 416, 498 Last update: 2022-07-06 |
Nasal Spray: 50 mcg/spray, 140 doses per container Cream/Ointment: 0.1% (15 g, 50 g) Lotion: 0.1% (30 mL) |
Nasal Spray Allergic rhinitis 2-11 yrs: 1 spray into each nostril once daily >12 yrs: 2 sprays into each nostril once daily 3-15 yrs: 1 spray into each nostril once daily x 6 weeks, then daily for the first 2 weeks of each month >2 yrs: Apply a thin film to affected areas once daily. Lotion: >12 yrs: Apply a few drops to affected areas once daily. Massage lightly into skin. |
Nasal Spray Avoid using higher than recommended dosages; suppression of linear growth (ie, reduction of growth velocity), reduced bone mineral density, or hypercortisolism (Cushing syndrome) may occur; titrate to lowest effective dose. Reduction in growth velocity may occur when corticosteroids are administered to pediatric patients, even at recommended doses via intranasal route (monitor growth). Cream/Ointment/Lotion Do not use occlusive dressings. Do not use in pediatric patients for longer than 3 weeks. Discontinue therapy when control is achieved; reassess diagnosis if no improvement seen in 2 weeks. Due to a higher BSA to weight ratio, pediatric patients are at a greater risk of HPA axis suppression and Cushing syndrome compared to adults. Application of topical steroids over >20% of BSA in pediatric patients increases risk of HPA axis suppression. Standard Prescription: mometasone nasal spray:__sprays in each nostril__(frequency) mometasone lotion: apply drops to___(affected areas) ___ (frequency) mometasone cream/ointment: apply thin film to__(affected areas)__(frequency) |